In a recent study on esophageal adenocarcinomas, we observed that nuclear p62 showed an influence on response to chemotherapy in vitro, but to a lesser degree compared to cytoplasmic p62. The gene discussed is SQSTM1; the disease is esophageal adenocarcinoma.